European Respiratory Society Monograph, Vol. 52. 2011
ISBN: 978-1-84984-011-8
DOI: 10.1183/1025448x.erm5210
Bronchiectasis has been a well-known disease for a long time. Following the introduction of antibiotic treatment in clinical practice for respiratory tract infections, the problem of bronchiectasis appeared to be solved, with some exceptions, e.g. in diseases such as cystic fibrosis. However, bronchiectasis is associated with a number of immunological diseases and occurs as a long-term complication of chronic lung diseases. These types of diseases, mainly chronic obstructive pulmonary disease, have become more and more prevalent, which has again made bronchiectasis a disease of interest. Unfortunately, most of the evidence regarding bronchiectasis is from case series and uncontrolled studies. Bronchiectasis has not been a focus of the pharmaceutical industry and randomised controlled studies have never been performed. Specific guidelines focusing on bronchiectasis are yet to be published.
Guest Editors
Eur Respir Monogr 2011; 52: v | |
Preface T. Welte Eur Respir Monogr 2011; 52: vi | |
Introduction R.A. Floto, C.S. Haworth Eur Respir Monogr 2011; 52: vii | |
Bronchiectasis: epidemiology and causes D. Bilton, A.L. Jones Eur Respir Monogr 2011; 52: 1-10 | |
Pulmonary defence mechanisms and inflammatory pathways in bronchiectasis B.N. Lambrecht, K. Neyt, C.H. GeurtsvanKessel Eur Respir Monogr 2011; 52: 11-21 | |
Histopathology of bronchiectasis M. Goddard Eur Respir Monogr 2011; 52: 22-31 | |
Assessment and investigation of adults with bronchiectasis M. Drain, J.S. Elborn Eur Respir Monogr 2011; 52: 32-43 | |
Radiological features of bronchiectasis P.L. Perera, N.J. Screaton Eur Respir Monogr 2011; 52: 44-67 | |
Microbiology of non-CF bronchiectasis J.E. Foweraker, D. Wat Eur Respir Monogr 2011; 52: 68-96 | |
Allergic bronchopulmonary aspergillosis and other fungal diseases B. Hilvering, J. Speirs, C.K. van der Ent, J.M. Beekman Eur Respir Monogr 2011; 52: 97-114 | |
Nontuberculous mycobacterial infections C.L. Daley Eur Respir Monogr 2011; 52: 115-129 | |
Ciliary dyskinesias: primary ciliary dyskinesia in adults L.J. Lobo, M.A. Zariwala, P.G. Noone Eur Respir Monogr 2011; 52: 130-149 | |
Channelopathies in bronchiectasis I. Sermet-Gaudelus, A. Edelman, I. Fajac Eur Respir Monogr 2011; 52: 150-162 | |
Bronchiectasis associated with inflammatory bowel disease Ph. Camus, T.V. Colby Eur Respir Monogr 2011; 52: 163-177 | |
Immunodeficiencies associated with bronchiectasis J.S. Brown, H. Baxendale, R.A. Floto Eur Respir Monogr 2011; 52: 178-191 | |
Bronchiectasis and autoimmune disease D.J. Dhasmana, R. Wilson Eur Respir Monogr 2011; 52: 192-210 | |
Antibiotic treatment strategies in adults with bronchiectasis C.S. Haworth Eur Respir Monogr 2011; 52: 211-222 | |
Anti-inflammatory therapies in bronchiectasis D.J. Smith, A.B. Chang, S.C. Bell Eur Respir Monogr 2011; 52: 223-238 | |
Pharmacological airway clearance strategies in bronchiectasis P.T. Bye, E.M.T. Lau, M.R. Elkins Eur Respir Monogr 2011; 52: 239-247 | |
Surgery for bronchiectasis D.C. Mauchley, J.D. Mitchell Eur Respir Monogr 2011; 52: 248-257 | |
Conclusions and future developments R.A. Floto Eur Respir Monogr 2011; 52: 258-261 | |